Detalhe da pesquisa
1.
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease.
Immunity
; 56(3): 669-686.e7, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889306
2.
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
Cell
; 166(6): 1459-1470.e11, 2016 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27610570
3.
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
Proc Natl Acad Sci U S A
; 120(24): e2216612120, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276407
4.
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.
Immunity
; 45(1): 31-45, 2016 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27438765
5.
A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.
J Immunol
; 207(1): 344-351, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34183368
6.
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
J Immunol
; 207(3): 878-887, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301847
7.
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
J Immunol
; 206(1): 109-117, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208457
8.
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows.
Nature
; 548(7665): 108-111, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28726771
9.
Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools.
Biotechnol Bioeng
; 119(2): 663-666, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796474
10.
Proof of principle for epitope-focused vaccine design.
Nature
; 507(7491): 201-6, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24499818
11.
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
PLoS Pathog
; 12(9): e1005905, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27627763
12.
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
PLoS Pathog
; 12(8): e1005815, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27560183
13.
Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins.
Sci Transl Med
; 16(735): eadk1867, 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381847
14.
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution.
Sci Signal
; 16(798): eabk3516, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582161
15.
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.
iScience
; 25(9): 104914, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971553
16.
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease.
bioRxiv
; 2022 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35291291
17.
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
bioRxiv
; 2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758848
18.
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening.
Cell Rep
; 36(9): 109627, 2021 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416153
19.
Structural basis of a public antibody response to SARS-CoV-2.
bioRxiv
; 2020 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577642
20.
Structural basis of a shared antibody response to SARS-CoV-2.
Science
; 369(6507): 1119-1123, 2020 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661058